STE vs. BDX, EW, IDXX, RMD, DXCM, PODD, HOLX, BAX, GMED, and MASI
Should you be buying STERIS stock or one of its competitors? The main competitors of STERIS include Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Insulet (PODD), Hologic (HOLX), Baxter International (BAX), Globus Medical (GMED), and Masimo (MASI). These companies are all part of the "health care equipment" industry.
STERIS vs.
STERIS (NYSE:STE) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, community ranking, analyst recommendations, profitability, dividends, valuation and earnings.
STERIS currently has a consensus price target of $262.50, indicating a potential upside of 25.30%. Becton, Dickinson and Company has a consensus price target of $283.50, indicating a potential upside of 19.33%. Given STERIS's higher probable upside, equities analysts clearly believe STERIS is more favorable than Becton, Dickinson and Company.
Becton, Dickinson and Company received 262 more outperform votes than STERIS when rated by MarketBeat users. Likewise, 62.32% of users gave Becton, Dickinson and Company an outperform vote while only 58.98% of users gave STERIS an outperform vote.
Becton, Dickinson and Company has a net margin of 8.55% compared to STERIS's net margin of 8.02%. Becton, Dickinson and Company's return on equity of 14.89% beat STERIS's return on equity.
STERIS pays an annual dividend of $2.28 per share and has a dividend yield of 1.1%. Becton, Dickinson and Company pays an annual dividend of $4.16 per share and has a dividend yield of 1.8%. STERIS pays out 52.1% of its earnings in the form of a dividend. Becton, Dickinson and Company pays out 70.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. STERIS has increased its dividend for 20 consecutive years and Becton, Dickinson and Company has increased its dividend for 53 consecutive years. Becton, Dickinson and Company is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Becton, Dickinson and Company has higher revenue and earnings than STERIS. Becton, Dickinson and Company is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks.
94.7% of STERIS shares are held by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are held by institutional investors. 1.1% of STERIS shares are held by insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
In the previous week, Becton, Dickinson and Company had 24 more articles in the media than STERIS. MarketBeat recorded 30 mentions for Becton, Dickinson and Company and 6 mentions for STERIS. STERIS's average media sentiment score of 1.64 beat Becton, Dickinson and Company's score of 0.81 indicating that STERIS is being referred to more favorably in the media.
STERIS has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500. Comparatively, Becton, Dickinson and Company has a beta of 0.39, indicating that its stock price is 61% less volatile than the S&P 500.
Summary
Becton, Dickinson and Company beats STERIS on 12 of the 21 factors compared between the two stocks.
Get STERIS News Delivered to You Automatically
Sign up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (NYSE:STE) was last updated on 1/20/2025 by MarketBeat.com Staff
